ANIK

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -1.90
Percentage change -11.10	%

Peers: AMGN VRTX REGN BMRN BIIB GILD SRPT INCY NBIX IONS

| Held by: VTI IWM VXF IWN DFAT SCHA VTWO ITOT DFAS IWC

Index	RUT	P/E	-	EPS (ttm)	-6.64	Insider Own	3.50%	Shs Outstand	14.65M	Perf Week	-10.53%
Market Cap	222.76M	Forward P/E	26.92	EPS next Y	0.56	Insider Trans	0.00%	Shs Float	14.13M	Perf Month	-14.36%
Income	-97.52M	PEG	-	EPS next Q	-0.02	Inst Own	86.01%	Short Float	2.64%	Perf Quarter	-11.72%
Sales	164.17M	P/S	1.36	EPS this Y	-118.75%	Inst Trans	-5.10%	Short Ratio	5.28	Perf Half Y	-38.15%
Book/sh	12.24	P/B	1.24	EPS next Y	1983.33%	ROA	-34.86%	Short Interest	0.37M	Perf Year	-41.02%
Cash/sh	3.80	P/C	4.00	EPS next 5Y	43.22%	ROE	-43.31%	52W Range	15.40 - 29.11	Perf YTD	-7.59%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-54.79%	52W High	-47.76%	Beta	0.75
Dividend TTM	-	Quick Ratio	3.78	Sales past 5Y	9.88%	Gross Margin	48.59%	52W Low	-1.23%	ATR (14)	0.69
Dividend Ex-Date	-	Current Ratio	5.34	EPS Y/Y TTM	-295.83%	Oper. Margin	-19.13%	RSI (14)	28.17	Volatility	3.84% 3.26%
Employees	357	Debt/Eq	0.16	Sales Y/Y TTM	0.52%	Profit Margin	-59.40%	Recom	1.00	Target Price	24.00
Option/Short	Yes / Yes	LT Debt/Eq	0.16	EPS Q/Q	65.13%	Payout	-	Rel Volume	2.02	Prev Close	17.11
Sales Surprise	5.52%	EPS Surprise	86.67%	Sales Q/Q	-28.78%	Earnings	Mar 12 AMC	Avg Volume	70.62K	Price	15.21
SMA20	-11.67%	SMA50	-9.92%	SMA200	-30.12%	Trades		Volume	141,345	Change	-11.10%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-01-24	Reiterated	Barrington Research	Outperform	$37 → $25
Aug-14-23	Upgrade	Barrington Research	Mkt Perform → Outperform	$24
Mar-07-23	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-09-22	Upgrade	Barrington Research	Mkt Perform → Outperform	$31
Oct-14-22	Resumed	Stephens	Equal-Weight	$26
Mar-09-22	Downgrade	Stephens	Overweight → Equal-Weight	$35
Mar-09-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-16-21	Initiated	Stephens	Overweight	$55
Jul-16-21	Initiated	UBS	Neutral	$46
Dec-16-20	Upgrade	Barrington Research	Mkt Perform → Outperform	$43
May-08-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Jan-21-20	Upgrade	Sidoti	Neutral → Buy	$61
Jan-10-20	Upgrade	First Analysis Sec	Outperform → Strong Buy	$65
Nov-05-19	Initiated	BWS Financial	Sell	$29
Sep-24-19	Reiterated	Barrington Research	Outperform	$49 → $58
Sep-23-19	Downgrade	First Analysis Sec	Strong Buy → Outperform	$54
Jul-25-19	Upgrade	First Analysis Sec	Neutral → Strong Buy	$37 → $54
Feb-22-19	Downgrade	Sidoti	Buy → Neutral	$56 → $41
Feb-22-19	Downgrade	First Analysis Sec	Outperform → Neutral	$41 → $37
Jul-27-18	Upgrade	Barrington Research	Mkt Perform → Outperform	$48

Show Previous Ratings

Today 06:43AM	Q4 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -11.10%
03:09AM	Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Mar-12-25 05:25PM	Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:33PM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
06:00AM	Loading…
Mar-07-25 06:00AM	Anika Completes Divestiture of Parcus Medical (GlobeNewswire)
Mar-01-25 06:42AM	Is Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stocks to Buy Now? (Insider Monkey)
Feb-26-25 08:00AM	Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025 (GlobeNewswire)
Feb-25-25 08:00AM	Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference (GlobeNewswire)
Dec-23-24 04:01PM	Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-03-24 08:30AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESS Newswire)
Nov-22-24 04:16PM	Anika To Participate in December 2024 Investor Conferences (GlobeNewswire)
Nov-01-24 03:07AM	Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... (GuruFocus.com)
Oct-31-24 11:00AM	Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics (PR Newswire) -30.67%
08:25AM	Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:18AM	Loading…
07:18AM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Third Quarter 2024 Financial Results (GlobeNewswire)
07:00AM	Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical (GlobeNewswire)
Oct-30-24 09:19AM	Anika Therapeutics Inc (ANIK) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-17-24 04:01PM	Anika Announces Third Quarter 2024 Results Conference Call Date (GlobeNewswire)
Oct-09-24 06:04PM	Anika Therapeutics Inc (ANIK) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Oct-04-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-09-24 04:45PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-15-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-09-24 07:41AM	Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock? (Insider Monkey)
Aug-08-24 06:35PM	Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates (Zacks)
05:27PM	Anika: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-05-24 04:01PM	Anika to Participate in the Sidoti Virtual Investor Conference (GlobeNewswire)
Jul-25-24 09:00AM	Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (GlobeNewswire)
07:19AM	Loading…
Jul-16-24 07:19AM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-11-24 08:30AM	Anika Announces Full Market Release of the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs (GlobeNewswire)
Jul-01-24 10:35AM	Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research (GlobeNewswire)
Jun-07-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-28-24 04:05PM	Anika Enters into Cooperation Agreement with Caligan Partners (GlobeNewswire)
May-09-24 12:22PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript (Insider Monkey) -11.28%
10:59AM	Q1 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
04:07AM	Anika Therapeutics Inc (ANIK) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ... (GuruFocus.com)
May-08-24 08:57PM	ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:40PM	Anika: Q1 Earnings Snapshot (Associated Press Finance)
04:08PM	Anika Announces CFO Transition (GlobeNewswire)
04:05PM	Anika Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-03-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-18-24 04:01PM	Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (GlobeNewswire)
Apr-02-24 08:00AM	Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-16-24 03:15PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-14-24 08:18AM	Q4 2023 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-13-24 04:47PM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Fourth Quarter and Year-End 2023 Financial Results (GlobeNewswire)
Mar-08-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-27-24 04:01PM	Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024 (GlobeNewswire)
Feb-13-24 09:00AM	Anika Highlights Its Recently Launched Integrity Implant System and RevoMotion Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting (GlobeNewswire)
Nov-28-23 09:00AM	Anika Announces First Surgeries Performed using the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release (GlobeNewswire)
Nov-07-23 04:05PM	Anika to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-05-23 02:26PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-03-23 09:43AM	Q3 2023 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) +11.22%
Nov-02-23 06:11PM	Anika Therapeutics Inc (ANIK) Reports 3% Revenue Growth in Q3 2023, Raises Full-Year Guidance (GuruFocus.com)
05:00PM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business (GlobeNewswire)
Oct-10-23 09:00AM	Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023 (GlobeNewswire)
Oct-04-23 07:18AM	Novavax (NVAX) Soars 8.2%: Is Further Upside Left in the Stock? (Zacks)
Oct-03-23 09:11AM	NRx Pharma (NRXP) to Initiate Clinical Study on NRX-101, Stock Up (Zacks)
Sep-19-23 09:00AM	Sidoti Events, LLCs Virtual September Small-Cap Conference (ACCESSWIRE)
09:00AM	Anika Announces the Full Market Release of the RevoMotion Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting (GlobeNewswire)
Sep-15-23 07:44PM	Seagate Stock, Gulfport Energy, and More See Action From Activist Investors (Barrons.com)
04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-12-23 09:00AM	Anika to Participate in the Sidoti Small Cap Virtual Investor Conference (GlobeNewswire)
Sep-01-23 06:51PM	Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
09:35AM	Down -20.42% in 4 Weeks, Here's Why You Should You Buy the Dip in Anika (ANIK) (Zacks)
Aug-31-23 12:00PM	All You Need to Know About Anika (ANIK) Rating Upgrade to Buy (Zacks)
09:35AM	Anika (ANIK) Loses -19.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Aug-22-23 07:22AM	3 Sorry Penny Stocks to Sell in August Before Its Too Late (InvestorPlace)
Aug-17-23 06:20PM	Anika Receives 510(k) Clearance for Integrity Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs (GlobeNewswire)
11:02AM	Caligan Partners LP Boosts Stake in Anika Therapeutics Inc (GuruFocus.com)
Aug-14-23 09:59AM	Marriott downgraded, Okta upgraded: Wall Street's top analyst calls (The Fly)
Aug-11-23 07:07AM	Anika Therapeutics, Inc.'s (NASDAQ:ANIK) Intrinsic Value Is Potentially 92% Above Its Share Price (Simply Wall St.)
Aug-09-23 09:03AM	Q2 2023 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-08-23 06:55PM	Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:40PM	Anika: Q2 Earnings Snapshot (AP Finance)
04:05PM	Anika Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-03-23 07:33PM	10 Oversold Small Cap Stocks To Buy (Insider Monkey)
Jul-20-23 04:05PM	Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023 (GlobeNewswire)
Jul-12-23 09:00AM	Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting (GlobeNewswire)
Jun-21-23 08:00PM	ANIK: Lowering target price to $22.00 (Argus Research)
May-30-23 04:05PM	Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone (GlobeNewswire)
May-15-23 09:19AM	With 77% ownership of the shares, Anika Therapeutics, Inc. (NASDAQ:ANIK) is heavily dominated by institutional owners (Simply Wall St.)
May-09-23 07:15PM	Anika Therapeutics (ANIK) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:08PM	Anika: Q1 Earnings Snapshot (AP Finance)
04:05PM	Anika Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-26-23 08:00PM	ANIK: Lowering target price to $28.00 (Argus Research)
Apr-19-23 11:32AM	The past five years for Anika Therapeutics (NASDAQ:ANIK) investors has not been profitable (Simply Wall St.)
08:30AM	Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023 (GlobeNewswire)
Apr-13-23 05:44PM	UPDATE 1-Anika Therapeutics reaches settlement with activist investor Caligan (Reuters)
05:00PM	Anika Enters Into Cooperation Agreement with Caligan Partners (GlobeNewswire)
Apr-12-23 09:00AM	Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-03-23 09:00AM	Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA (GlobeNewswire)
Mar-27-23 04:55PM	UPDATE 1-Caligan pushes ahead with board challenge at Anika, nominates two directors (Reuters)
04:19PM	Caligan pushes ahead with board challenge at Anika, nominates two directors (Reuters)
08:55AM	Anika Files Preliminary Proxy Statement (GlobeNewswire)
Mar-20-23 06:15PM	Anika Therapeutics (ANIK) Stock Sinks As Market Gains: What You Should Know (Zacks)

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Insider Trading	Relationship	Date	Transaction	#Shares	#Shares Total	SEC Form 4
Nunes Anne	SVP, Chief Operations Officer	Mar 10 '25	Option Exercise	3,296	17,235	Mar 11 05:18 PM
Colleran David	EVP, General Counsel, Corp Sec	Mar 10 '25	Option Exercise	5,465	39,590	Mar 11 05:17 PM
Blanchard Cheryl R	President, CEO, Director	Mar 10 '25	Option Exercise	20,002	172,826	Mar 11 05:17 PM
Nunes Anne	SVP, Chief Operations Officer	Oct 01 '24	Option Exercise	2,491	14,211	Oct 04 04:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Anika Therapeutics Inc

Upgrade your FINVIZ experience